-
公开(公告)号:AR192762A1
公开(公告)日:1973-03-14
申请号:AR24144572
申请日:1972-04-13
Applicant: HOECHST AG
Inventor: KUCH H , HOFFMANN I
IPC: C07D243/12 , C07F9/53 , C07F9/645
Abstract: Dialkylphosphinylalkylene-substituted 1,5-benzodiazepines useful as medicaments in the treatment of psychic diseases are obtainable by reacting the corresponding benzodiazepines with a dialkyl-phosphinylalkyl halide or by reacting a 2-dialkyl-phosphinylalkylaminodiphenylamine with a malonic acid dihalide or alkylmalonic acid dihalide.
-
公开(公告)号:ZA7202518B
公开(公告)日:1973-01-31
申请号:ZA7202518
申请日:1972-04-14
Applicant: HOECHST AG
Inventor: KUCH H , HOFFMANN I
IPC: C07D243/12 , C07F9/53 , C07F9/645 , C07D
CPC classification number: C07F9/645 , C07F9/5304
-
公开(公告)号:SE329620B
公开(公告)日:1970-10-19
申请号:SE1601767
申请日:1967-11-22
Applicant: HOECHST AG
Inventor: KUCH H , SCHMITT K , SEIDL G , HOFFMANN I
IPC: C07D265/18 , C07D87/20
Abstract: 2-Amino-4,4-di-substituted benzoxazine derivatives and the salts thereof with a physiologically compatible acid have an action on the central nervous system. These benzoxazines have the formula IN WHICH R is hydrogen, alkyl of one to four carbon atoms, cyclohexyl, phenyl or benzyl, R1 is hydrogen, halogen, trifluoromethyl, R2 is alkyl of one to four carbon atoms and R3 is phenyl or halophenyl.
-
公开(公告)号:NO119681B
公开(公告)日:1970-06-22
申请号:NO16327566
申请日:1966-06-02
Applicant: HOECHST AG
Inventor: KUCH H , SEIDL G , HOFFMANN I
IPC: B02C18/06 , C07D219/02 , C07D219/04 , C07D219/06 , C07D219/14 , C07D265/18 , C07D265/38
Abstract: (A) 3,1-Benzothiazines and 3,1-benzoxazines of gen. formula (I), where A = O or S R = H, alkyl, cycloalkyl, alkenyl, cycloalkenyl aryl, aralkyl, or lower dialkylaminoalkyl in which the dialkylamino group can also be cyclized via O, S, or methyl- or benzylimino, R1 = H, halogen, methoxy, CF3, NO2 R2 = alkyl, aralkyl, or aryl, in which the benzene rings of the last two can be substituted by halogen, methoxy, CF3, NO2. (B) Salts of I formed with organic and inorganic acids. Compounds (1) combine valuable pharmacological properties with very low toxicity. They are central depressants, as well as stimulants, sedatives, noradrenaline potentiators, analgesics and spasmolytics, and they prolong narcosis. They are useful in the treatment of mental diseases, e.g. depression, psychioneuroses, disturbances and anxiety states of neurotic and psychotic patients.
-
公开(公告)号:DK162682A
公开(公告)日:1982-10-10
申请号:DK162682
申请日:1982-04-07
Applicant: HOECHST AG
IPC: A61K31/40 , A61K31/403 , A61K31/404 , A61P25/28 , C07D209/34 , C07D209/36 , C07D209/38 , C07D295/185 , C07D
Abstract: Oxindole derivatives of the general formula I (I) are described, and also processes for their preparation and drugs containing them. The new compounds exhibit a neuroanabolic action in various animal models.
-
公开(公告)号:CH572066A5
公开(公告)日:1976-01-30
申请号:CH1345375
申请日:1972-04-12
Applicant: HOECHST AG
Inventor: KUCH H , HOFFMANN I
IPC: C07D243/12 , C07F9/53 , C07F9/645
Abstract: Dialkylphosphinylalkylene-substituted 1,5-benzodiazepines useful as medicaments in the treatment of psychic diseases are obtainable by reacting the corresponding benzodiazepines with a dialkyl-phosphinylalkyl halide or by reacting a 2-dialkyl-phosphinylalkylaminodiphenylamine with a malonic acid dihalide or alkylmalonic acid dihalide.
-
公开(公告)号:CH570414A5
公开(公告)日:1975-12-15
申请号:CH535772
申请日:1972-04-12
Applicant: HOECHST AG
Inventor: KUCH H , HOFFMANN I
IPC: C07D243/12 , C07F9/53 , C07F9/645
Abstract: Dialkylphosphinylalkylene-substituted 1,5-benzodiazepines useful as medicaments in the treatment of psychic diseases are obtainable by reacting the corresponding benzodiazepines with a dialkyl-phosphinylalkyl halide or by reacting a 2-dialkyl-phosphinylalkylaminodiphenylamine with a malonic acid dihalide or alkylmalonic acid dihalide.
-
公开(公告)号:FI48595B
公开(公告)日:1974-07-31
申请号:FI316967
申请日:1967-11-24
Applicant: HOECHST AG
Inventor: KUCH H , SCHMITT K , SEIDL G , HOFFMANN I
IPC: C07D265/18 , C07D87/20
Abstract: 2-Amino-4,4-di-substituted benzoxazine derivatives and the salts thereof with a physiologically compatible acid have an action on the central nervous system. These benzoxazines have the formula IN WHICH R is hydrogen, alkyl of one to four carbon atoms, cyclohexyl, phenyl or benzyl, R1 is hydrogen, halogen, trifluoromethyl, R2 is alkyl of one to four carbon atoms and R3 is phenyl or halophenyl.
-
公开(公告)号:ZA722518B
公开(公告)日:1973-01-31
申请号:ZA722518
申请日:1972-04-14
Applicant: HOECHST AG
Inventor: KUCH H , HOFFMANN I
IPC: C07F9/53 , C07D243/12 , C07F9/645 , C07D
Abstract: Dialkylphosphinylalkylene-substituted 1,5-benzodiazepines useful as medicaments in the treatment of psychic diseases are obtainable by reacting the corresponding benzodiazepines with a dialkyl-phosphinylalkyl halide or by reacting a 2-dialkyl-phosphinylalkylaminodiphenylamine with a malonic acid dihalide or alkylmalonic acid dihalide.
-
公开(公告)号:FR2133751A1
公开(公告)日:1972-12-01
申请号:FR7213212
申请日:1972-04-14
Applicant: HOECHST AG
Inventor: KUCH H , HOFFMANN I
IPC: C07F9/53 , C07F9/645 , C07D243/12 , A61K27/00 , C07F9/00
Abstract: Dialkylphosphinylalkylene-substituted 1,5-benzodiazepines useful as medicaments in the treatment of psychic diseases are obtainable by reacting the corresponding benzodiazepines with a dialkyl-phosphinylalkyl halide or by reacting a 2-dialkyl-phosphinylalkylaminodiphenylamine with a malonic acid dihalide or alkylmalonic acid dihalide.
-
-
-
-
-
-
-
-
-